



















































Quality Standards and Guidance
for Program Evaluation
A Report of the National Vaccine
Advisory Committee
and
Use of Standing Orders Programs
to Increase Adult Vaccination Rates
Recommendations of the Advisory
Committee on Immunization Practices
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Atlanta, GA 30333


































2 MMWR January 21, 2000
Centers for Disease Control and Prevention ........................... Jeffrey P. Koplan, M.D., M.P.H.
Director
The material in this report was prepared for publication by
Epidemiology Program Office ................................................... Barbara R. Holloway, M.P.H.
Acting Director
Division of Prevention Research
and Analytic Methods ......................................................... Jeffrey R. Harris, M.D., M.P.H.
Director
National Immunization Program .................................................. Walter A. Orenstein, M.D.
Director
Epidemiology and Surveillance Division ................................... John R. Livengood, M.D.
Director
Immunization Services Division ................................................. Lance E. Rodewald, M.D.
Acting Director
National Vaccine Program Office ..................................................... Martin G. Meyers, M.D.
Acting Director
The production of this report as an MMWR serial publication was coordinated in
Epidemiology Program Office ................................................... Barbara R. Holloway, M.P.H.
Acting Director
Office of Scientific and Health Communications .............................. John W. Ward, M.D.
Director
Editor, MMWR Series





......................................................................................................... Cheryle  R. Reynolds
Visual Information Specialist
The MMWR series of publications is published by the Epidemiology Program Office,
Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human
Services, Atlanta, GA 30333.
SUGGESTED CITATION
Centers for Disease Control and Prevention. Adult immunization programs in nontradi-
tional settings: quality standards and guidance for program evaluation—a report of the
National Vaccine Advisory Committee and Use of standing orders programs to increase
adult vaccination rates: recommendations of the Advisory Committee on Immunization
Practices. MMWR 2000;49(No. RR-1):[inclusive page numbers].



















































Adult Immunization Programs in Nontraditional Settings: Quality Standards
  and Guidance for Program Evaluation........................................................... 1
Background ................................................................................................. 1
Introduction ................................................................................................. 2
Purpose of the National Vaccine Advisory Committee Workshop .... 2
Workshop Participants .......................................................................... 3
Summary of Workshop Presentations ....................................................... 3
Examples of Adult Immunization Programs
   in Nontraditional Settings ................................................................. 3
New Settings and Incentives for Immunization Programs ................ 4
Benefits of Adult Immunization Programs in Nontraditional Settings .... 5
Access and Convenience ...................................................................... 5
Reduced Cost for Vaccinations ............................................................ 5
Increased Awareness for Vaccinations Among Adults ....................... 5
Challenges of Adult Immunization Programs
   in Nontraditional Settings ....................................................................... 5
Adverse Reactions to Vaccines ............................................................ 5
Recordkeeping ...................................................................................... 6
Liability of Health-Care Providers ........................................................ 6
Legal Regulations ................................................................................. 6
Integrating Vaccine Programs in Nontraditional
   and Traditional Settings..................................................................... 6
Quality of Services ................................................................................ 7
Future Considerations and Priorities ......................................................... 7
Guidance From NVAC for Conducting Adult Immunization Programs
  in Nontraditional Settings ........................................................................ 8
Standard 1: Information and Education for Vaccinees ....................... 8
Standard 2: Vaccine Storage and Handling......................................... 8
Standard 3: Immunization History ....................................................... 9
Standard 4: Contraindications ............................................................. 9
Standard 5: Recordkeeping .................................................................. 9
Standard 6: Vaccine Administration .................................................. 11
Standard 7: Adverse Events ............................................................... 11
Conclusion ................................................................................................. 11
References ................................................................................................. 12
Use of Standing Orders Programs to Increase Adult Vaccination Rates .... 15
Introduction ............................................................................................... 21
Background ............................................................................................... 21
Implementation Guidelines ...................................................................... 23
Conclusion ................................................................................................. 24
References ................................................................................................. 24
ii MMWR March 24, 2000
References to non-CDC sites on the Internet are provided as a service to MMWR
readers and do not constitute or imply endorsement of these organizations or
their programs by CDC or the U.S. Department of Health and Human Services.
CDC is not responsible for the content of pages found at these sites.
Use of trade names and commercial sources is for identification only and does not
imply endorsement by the U.S. Department of Health and Human Services.
Copies can be purchased from Superintendent of Documents, U.S. Government
Printing Office, Washington, DC 20402-9325. Telephone: (202) 512-1800.
Vol. 49 / No. RR-1 MMWR iii
National Vaccine Advisory Committee Membership List
Myron Levine, M.D.











Josiah Macy, Jr. Foundation









Mayo Clinic and Foundation
Rochester, Minnesota
































National Vaccine Program Office, CDC
Atlanta, Georgia
PAST CHAIRMAN





National Vaccine Program Office, CDC
Atlanta, Georgia
MEMBERS
iv MMWR March 24, 2000
National Vaccine Advisory Committee
Membership List — Continued
David Benor, J.D.
Office of General Counsel
Rockville, Maryland
William Egan, Ph.D.
Food and Drug Administration
Rockville, Maryland
Col. Renata Engler, M.D.
Department of Defense/
Walter Reed Medical Center
Washington, D.C.
Geoffrey Evans, M.D.







































University of Medicine and
Dentistry/Robert Wood Johnson
Medical School





Vol. 49 / No. RR-1 MMWR v
American Academy of Nurse
Practitioners
American Academy of Family
Physicians
American Academy of Pediatrics
American Association of
Occupational Health Nurses
American Association of Retired
Persons
American College of Nurse
Midwives
American College of Physicians
American Dental Association







Association of State and Territorial
Dental Directors









Food and Drug Administration









Healthy Mothers, Healthy Babies
Coalition
International Health Corporation
Little Havana Activities and Nutrition
Centers of Dade County, Inc.















vi MMWR March 24, 2000
Mississippi Board of Pharmacy
Mollen Immunization Clinics







National Black Nurses Association
National Center for Infectious
Diseases, CDC
National Coalition for Adult
Immunization
National Coalition of Hispanic
Health and Human Services
WORKSHOP PARTICIPANTS — CONTINUED
National Council of La Raza
National Council on the Aging, Inc.
National Immunization Program
CDC
National Institute for Allergy
and Infectious Diseases
National Institutes of Health
National Medical Association
Office of Minority Health, CDC
SmithKline Beecham
Pharmaceuticals




Vol. 49 / No. RR-1 MMWR vii
The following CDC staff members prepared this report:
  Alicia S. Postema, M.P.H.
  Robert F. Breiman, M.D.
National Vaccine Program Office
Office of the Director
viii MMWR March 24, 2000
Vol. 49 / No. RR-1 MMWR 1
Adult Immunization Programs
in Nontraditional Settings:
Quality Standards and Guidance
for Program Evaluation
A Report of the National Vaccine Advisory Committee
Summary
This report provides a summary of the National Vaccine Advisory
Committee’s (NVAC) workshop on adult immunization programs in
nontraditional settings, quality standards for such programs, and guidance for
program evaluation. Throughout the United States, an increasing number of
adults are receiving vaccine in nontraditional settings (e.g., pharmacies and
churches). Immunization programs in nontraditional settings are often more
accessible and convenient than a health-care provider’s office or a public health
clinic, especially for medically underserved adults (e.g., economically
disadvantaged, inner city, and minority populations). Medically underserved
adults might be at particular risk for undervaccination because they are often
without a medical home (i.e., a regular point of contact where their health-care
needs are met). Immunization programs in nontraditional settings might
enhance the capacity of the health-care system to effectively deliver vaccine to
adults by increasing the number and types of sites where adults can receive
vaccine. NVAC has recognized that strategies need to be developed to make
vaccines available to all adults and that the number of immunization programs in
nontraditional settings is increasing. Therefore, the Committee issues the
following report, including quality standards and guidance for program
evaluation.
BACKGROUND
Approximately 45,000 adults in the United States die annually of complications from
influenza, pneumococcal infections, and hepatitis B — the primary vaccine-preventable
diseases affecting adults. The total economic cost of treating these vaccine-
preventable diseases among adults, excluding the value of years of life lost, exceeds
$10 billion each year. Although effective vaccines to prevent these diseases are
available, they are widely underutilized (1,2 ). This underutilization reflects a lack of
emphasis on vaccines for adults in comparison with the more substantial emphasis on
vaccines for children.
Influenza and pneumococcal vaccine coverage rates for adults aged 65 years vary
by race and ethnicity (2 ). In 1997, influenza vaccine coverage rates ranged from 67.2%
among non-Hispanic whites to 50.2% among non-Hispanic blacks (2 ). Pneumococcal
vaccine coverage rates were even lower: 47.3% of white adults aged 65 years reported
receiving pneumococcal vaccine compared with 34.1% of Hispanics and 29.7% of blacks
(2 ). Disease burden also varies by race and ethnicity. Blacks have a threefold to fivefold
increased risk for developing life-threatening invasive pneumococcal disease compared
with whites (3–5 ).
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A recommendation by a health-care provider is a key factor determining whether an
adult patient will be vaccinated (6 ). Medically underserved adults (e.g., economically
disadvantaged, inner city, and minority populations) might be at particular risk for
underimmunization because they are often without a medical home (i.e., a regular point
of contact where their health-care needs are met) and might not have regular access to
a health-care provider (7–10 ). Therefore, to reach medically underserved adults, strat-
egies to increase vaccine-seeking behavior are critically needed. One such strategy
involves offering vaccine to adults in nontraditional settings (e.g., pharmacies and
churches) that might be more accessible and convenient than the office of a health-care
provider or a public health clinic. Immunization programs in nontraditional settings
might enhance the capacity of the health-care system to effectively deliver vaccine to
adults by increasing the number and types of settings in which adults can receive vac-
cine.
INTRODUCTION
Purpose of the National Vaccine Advisory
Committee Workshop
The National Vaccine Program Office sponsored a public meeting of the National
Vaccine Advisory Committee’s (NVAC) Adult Immunization Working Group on Decem-
ber 1–2, 1997, to explore adult immunization programs in nontraditional settings. The
purpose of the workshop was
• to gain a better understanding of programs currently offering vaccines to adults
in nontraditional settings,
• to identify potential benefits and challenges associated with administering
vaccines in nontraditional settings,
• to identify additional nontraditional settings that could be explored and
potentially used,
• to define areas where additional research is needed,
• to develop an effective immunization strategy integrating immunization
programs in nontraditional settings with those in traditional settings, and
• to develop quality standards for immunization programs in nontraditional
settings.
The workshop was limited to discussion regarding vaccines for adults because na-
tional vaccine coverage estimates for adults are substantially lower than the national
goals established for this population, whereas coverage estimates for children approach
or exceed national goals (2,7,11 ).
The purpose of this report is to provide a summary of discussions at the NVAC
workshop so that persons who conduct or plan to conduct immunization programs in a
nontraditional setting will have guidance regarding how to safely operate such a pro-
gram. This report also highlights the importance of evaluating these programs by col-
lecting data regarding associated benefits (e.g., increases in the number of adults vac-
cinated) and challenges (e.g., preventing fragmentation of care by reporting adminis-
tration of vaccine to the primary-care provider of the vaccinee).
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Influenza and pneumococcal vaccines constitute the majority of vaccines adminis-
tered in nontraditional settings; therefore, this report focuses on these vaccines. If the
types of vaccines administered in nontraditional settings increase, both the benefits
and challenges could change.
Workshop Participants
Workshop participants included members of the NVAC Adult Immunization Work-
ing Group and representatives from approximately 50 organizations, including federal
and state governments, community and professional organizations, and private com-
panies. Participants were identified through discussions with staff at CDC, the Health
Resources and Services Administration, the National Coalition for Adult Immunization
(NCAI), and other organizations. NCAI is composed of nearly 100 professional medical
and health-care associations, advocacy groups, voluntary organizations, vaccine manu-
facturers, and government agencies. Workshop presenters were selected to ensure that
a spectrum of viewpoints was represented.
SUMMARY OF WORKSHOP PRESENTATIONS
Information regarding the U.S. Department of Health and Human Services’ Adult
Immunization Action Plan (1 ), vaccine coverage rates, and incidence of morbidity and
mortality attributable to vaccine-preventable diseases among adults was presented.
The American College of Physicians (ACP) and the National Medical Association pro-
vided physicians’ perspectives of administration of vaccine in nontraditional settings.
The benefits and challenges highlighted by these physicians were similar to those of
other workshop participants. Benefits included increased access and convenience, re-
duced cost for vaccination, and increased awareness of the importance of vaccination.
Challenges included ensuring that trained staff are available to treat potential adverse
reactions to vaccines, keeping effective records, protecting health-care providers from
liability, preventing fragmentation of care, and removing restrictive legal regulations.
NCAI and the National Council on Aging emphasized the importance of collabora-
tion between public and private sectors and community-based organizations. A panel
of representatives from community-based organizations providing services to tradi-
tionally underserved populations presented ways in which their clients might be more
adequately cared for by the health-care profession (e.g., providing culturally and lin-
guistically appropriate materials and outreach programs). Organizations that currently
provide vaccines to adults in several nontraditional settings (including pharmacies,
nontraditional clinical settings, retail establishments, dental care facilities, churches,
the workplace, and the home) provided examples of the benefits and challenges expe-
rienced in these programs.
Examples of Adult Immunization Programs
in Nontraditional Settings
The Health Care Financing Administration’s (HCFA) Horizons pilot project, a collabo-
rative project between professional review organizations and nine historically black
colleges and universities in eight southern states, was presented as an example of how
the Federal government works with communities to provide vaccine in nontraditional
settings. The goal of the Horizons project is to produce effective community-based
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interventions for increasing vaccine coverage rates among black populations.
Tennessee’s Horizons project has provided vaccines to adults in approximately 14 non-
traditional settings, including shopping malls, senior citizen centers, nutrition sites, mo-
bile units, grocery stores, voting sites, parks, and public housing projects.
Pharmacies in the United States are increasing their participation in vaccination
activities (12 ). Pharmacists are functioning as a) vaccine advocates, by educating their
clients about the importance of vaccines; b) vaccine facilitators, by hosting vaccine
clinics at pharmacies; and c) vaccine administrators, by vaccinating their clients. The
American Pharmaceutical Association and CDC’s National Immunization Program have
developed a training course to prepare pharmacists for active participation in immuni-
zation programs (13 ). Twenty-six states have statutes that permit pharmacists to ad-
minister vaccine. Accessability of pharmacists and the degree of trust between phar-
macists and patients were suggested as factors that provide important opportunities
for pharmacists to educate adults about the benefits of vaccines and, in some cases,
administer vaccine.
Nurse practitioners, visiting nurses, and members of the National Black Nurses As-
sociation (NBNA) also are involved in immunization programs in nontraditional set-
tings. Nurse practitioners, using mobile-community health centers, often provide care
to traditionally underserved homeless and migrant workers and a large population of
older adults who reside in rural or inner city areas. NBNA and the Visiting Nurses Asso-
ciation often staff immunization programs operating in nontraditional settings, includ-
ing the workplace, pharmacies, and churches.
A representative from the American Association of Occupational Health Nurses
noted that employers can be involved in workplace immunization activities on three
levels: a) providing vaccines at the work site, administered by their own medical staff;
b) contracting with health-care providers to administer vaccine at the work site; and/or
c) including preventive care benefits (e.g., vaccinations) in health plans for employees.
Employers generally are interested in increasing employee productivity; therefore, de-
creased employee absenteeism associated with receiving influenza vaccine should be
highlighted (14 ). Potential barriers to workplace vaccination programs include employ-
ers being reluctant to disrupt work schedules or to offer vaccine to employees covered
by health plans. Workplaces with a small number of employees might not be able to
provide vaccination programs on their own but might be able to unite with other offices
and provide vaccines in a centralized site within an office park.
New Settings and Incentives for Immunization Programs
Several additional nontraditional settings in which vaccines might be provided in-
clude soup kitchens, prisons, sheltered workshops for persons with disabilities, casi-
nos, bingo halls, adult day care centers, major transit points, and polling stations on
election days. Designation of mass immunization days (analogous to national immuni-
zation days for polio vaccination in endemic areas [15 ]) during which vaccinations are
provided in several different settings was suggested. New incentive or endorsement
programs that might increase the demand for vaccinations were also presented. For
example, retail coupons and endorsement by sports teams were suggested as poten-
tial ways to enhance vaccine-seeking behavior among adults.
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BENEFITS OF ADULT IMMUNIZATION PROGRAMS
IN NONTRADITIONAL SETTINGS
Access and Convenience
The most common benefits of administering vaccine in nontraditional settings noted
by workshop presenters are increased access and convenience. Providing vaccines in
settings readily accessible to adults who are most in need of the services is critical. For
many adults, the need to use transportation to reach a health-care provider is a barrier
to receiving preventive services (7,9 ). This barrier might be eliminated by offering pre-
ventive services (e.g., administration of vaccines) in a neighborhood retail establish-
ment, church, or other convenient location. Eliminating the need for making an ap-
pointment in advance and avoiding the waiting time often associated with a clinic or
office visit are factors that also might increase the vaccine-seeking behavior of some
adults (8,9 ).
Reduced Cost for Vaccinations
The reduced cost of receiving vaccines in nontraditional settings compared with
traditional settings is another potential benefit. The current cost of administering influ-
enza and pneumococcal vaccines in a nontraditional setting is $10–$15 and $15–$20,
respectively. Adults without health insurance might be willing to pay for a vaccine ad-
ministered in a nontraditional setting when they would be unwilling or unable to pay
the greater cost associated with a physician’s office visit (16,17 ). For adults who are
covered by Medicare, HCFA has mandated reimbursement for health-care providers
who administer influenza vaccine, regardless of the setting, even if the health-care pro-
vider is not a member of the vaccinee’s health-care plan.
Increased Awareness for Vaccinations Among Adults
An indirect benefit of administering vaccine in nontraditional settings is increased
public awareness of the need for adult immunization. This benefit is realized in two
ways. First, many immunization programs operating in nontraditional settings use di-
rect marketing to inform the community about their services and why they are impor-
tant. Although marketing strategies might be directed toward promoting a specific site,
the actual benefit is likely a general increase in public awareness regarding the impor-
tance and availability of vaccines for adults. Secondly, immunization programs in non-
traditional settings often elicit media attention, which might increase community aware-
ness of the need for vaccination of adults.
CHALLENGES OF ADULT IMMUNIZATION PROGRAMS
IN NONTRADITIONAL SETTINGS
Adverse Reactions to Vaccines
Vaccine providers should be trained to manage adverse reactions that might occur.
Concerns regarding postvaccination observation included: “Should direct observation
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of vaccine recipients be routine? If so, what is the duration of observation? If a severe
adverse reaction occurs, are trained and skilled personnel on site to respond appropri-
ately?”
Recordkeeping
Important factors regarding recordkeeping include how to determine which adults
are in need of vaccines and how to prevent inappropriate revaccination.* Immuniza-
tion registries might play a role in resolving this issue; however, most existing immuni-
zation registries do not include information regarding adults. Until immunization regis-
tries routinely include this information, the primary-care provider and/or health depart-
ment should be notified when a vaccine is administered in a nontraditional setting so
that patient immunization records can be updated. In addition, vaccinees should be
provided with wallet-sized vaccine records. These efforts will help ensure that adults
are offered appropriately timed vaccines and that their vaccination status is accessible
to their health-care provider in traditional or nontraditional settings and to other health-
care providers who might offer them vaccines in nontraditional settings.
Liability of Health-Care Providers
Many workshop participants considered liability protection for health-care providers
an important component of any adult immunization program. Health-care providers might
be more likely to promote and administer vaccines if they could be assured of not being
held liable for incidents of rare but serious adverse reactions to vaccines.
Legal Regulations
Workshop participants described several restrictive legal regulations regarding the
administration of vaccines. In many states, legislation restricts who can administer vac-
cines and under what circumstances. In some areas, new immunization programs that
might reach populations at high risk for disease could be hampered by restrictive legal
regulations.
Integrating Vaccine Programs in Nontraditional
and Traditional Settings
One challenge of offering vaccines in a setting that does not provide other preven-
tive services is fragmentation of care. Workshop participants acknowledged the impor-
tance of having a medical home to ensure appropriate and comprehensive preventive
care, early diagnosis, and optimal therapy. Immunization programs in nontraditional
settings should facilitate identification of medical homes for medically underserved
adults who need a health-care provider. To promote integration of preventive care
*Influenza vaccine should not be routinely administered more than once during an influenza
season (18 ). Revaccination with pneumococcal vaccine one time, at least 5 years after initial
vaccination, is recommended for persons at highest risk for pneumococcal infection (e.g., persons
who are immunocompromised or who are asplenic) and those most likely to have a rapid
decline in antibody concentrations. In addition, for persons vaccinated before age 65 years, a
second dose should be administered at age 65 years, provided that 5 years have elapsed
since the first dose (19 ).
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services when an adult with a regular primary-care provider is vaccinated in a nontradi-
tional setting, the primary-care provider should be notified by the vaccine provider of
the patient’s vaccination status. Vaccination status is often a marker for other health-
care needs. Therefore, adults seeking vaccines in nontraditional settings also might
need other preventive health services (e.g., mammograms and lipid screenings). In
addition, these programs need systematic procedures (e.g., providing lists of nearby
physicians and offering to schedule appointments) to ensure that referrals to primary-
care providers are offered when appropriate and that relevant health promotion and
disease prevention literature are available on site.
Quality of Services
The mission of an immunization program and the motivation of the health-care
providers who operate the program might affect the quality of services provided. Im-
portant components of quality care when administering vaccines in nontraditional set-
tings include a) ability to handle adverse reactions, b) notification of the primary-care
provider or health department when vaccines are administered, c) physician referral
services, and d) providing education regarding other key preventive health measures.
FUTURE CONSIDERATIONS AND PRIORITIES
The conclusions reached by workshop participants were based primarily on expert
opinion and anecdotal information. Both workshop participants and NVAC recognize
the need for research targeted at providing data that addresses the effectiveness of
immunization programs in nontraditional settings in reaching previously unvaccinated
adults.
NVAC recommends that program evaluation be conducted to determine the impact
of immunization programs in nontraditional settings on vaccine coverage rates and
vaccine-preventive disease rates among adults. Specifically, the following concerns
should be addressed:
• Determine characteristics of persons receiving vaccine in nontraditional settings,
including demographic characteristics, previous vaccine-seeking behavior, and
previous and anticipated future use of the traditional medical system. A survey
of persons using nontraditional settings for vaccination could provide these data.
• Determine characteristics of programs successfully reaching hard-to-reach,
previously unvaccinated adults. Demonstration projects, including various types
of programs (e.g., those operated by service versus for-profit organizations) in
different locations, including churches, work sites, and pharmacies, need to be
assessed to determine which combination of features creates the most
successful program.
• Catalogue the types of services provided. The catalogue could include the
following features: reporting to primary-care physician, referral to physician,
provision of educational materials regarding the importance of other preventive
care measures, the number of programs offering each service, and the effect of
these services on program operating costs.
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• Determine if the nontraditional settings in which vaccines are administered are
accessible locations and settings in which medically underserved populations
feel comfortable receiving vaccine. This information could be obtained by
surveying these adults.
• Determine the potential effect of liability protection on physician practice pat-
terns by surveying physicians.
• Determine reasons nonphysician providers in some states are not allowed to
administer vaccines in nontraditional settings. These reasons could be ad-
dressed by surveying state legislators and health officials.
GUIDANCE FROM NVAC FOR CONDUCTING ADULT
IMMUNIZATION PROGRAMS IN NONTRADITIONAL SETTINGS
Although no formalized, coordinated effort to provide vaccinations in nontraditional
settings exists at the national level, many adults are already receiving vaccine in these
settings. To ensure the safety of persons receiving vaccines in these settings, NVAC has
established seven quality standards for vaccine providers conducting or planning to
conduct adult immunization programs in nontraditional settings.
Quality standards for immunization programs in nontraditional settings generally
coincide with the quality standards for programs in traditional settings. NVAC’s quality
standards for immunization programs in nontraditional settings are consistent with
existing adult immunization standards of the Advisory Committee on Immunization
Practices (ACIP) (20 ), ACP (21 ), the Infectious Disease Society of America (22 ), and
NCAI (23 ), with additional caveats specific to nontraditional settings.
Standard 1: Information and Education for Vaccinees
Before receiving vaccine, the vaccinee must be given information about the risks
and benefits associated with vaccination, including the CDC-developed Vaccination In-
formation Statements that address the risks and benefits for 12 commonly adminis-
tered vaccines, including influenza and pneumococcal vaccines. This information should
be culturally and linguistically appropriate and written at a reading level that can be
easily understood. The vaccine provider should be available to accurately address ques-
tions and concerns posed by the vaccinee.
Vaccinees should also be informed regarding the importance of having a medical
home and receiving other preventive medical services. In addition, health promotion
and disease prevention literature should be available on site and offered to the vac-
cinee.
Standard 2: Vaccine Storage and Handling
Adherence to vaccine handling and storage recommendations included in vaccine
package inserts is critical because mishandling and inappropriate storage can render
vaccines ineffective. Influenza and pneumococcal vaccines are the primary vaccines
administered in nontraditional settings. These vaccines should be stored at tempera-
tures between 2 C and 8 C (38 F and 48 F), and records of storage temperature should
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be maintained. Temperatures below freezing destroy the potency of these vaccines
(24 ). Vaccine providers are responsible for ensuring appropriate storage of vaccines
and should be trained accordingly. Storage procedures will become more complex if
the types of vaccine offered in nontraditional settings increase.
Standard 3: Immunization History
Prevaccination screening interviews should be conducted and immunization histo-
ries of vaccinees obtained before administering vaccines. At a minimum, the following
information should be obtained from the vaccinee: vaccines previously received, pre-
existing health conditions, allergies, and adverse events that occurred after previous
vaccinations. Consulting the vaccinee’s medical record is the most reliable method of
determining immunization status; however, this is not always feasible, especially among
adults receiving vaccines in nontraditional settings. In many cases, the medical record
might not be available or, if available, might not contain the most recent information,
particularly if a vaccine was not administered by the vaccinee’s primary-care provider.
Although repeated pneumococcal vaccination (especially within 24 months) might be
associated with local adverse reactions more severe than those occurring after initial
vaccination (19,25 ), ACIP and ACP recommend that the vaccine be offered when vacci-
nation status cannot be determined (19,21 ).
Standard 4: Contraindications
Before administering vaccine, vaccine providers must assess the presence of
contraindications. This assessment, part of the process of assessing the vaccinee’s im-
munization history (Standard 3), should be made during the prevaccination screening
interview. If a contraindication to immunization exists, this information should be pro-
vided to the primary-care provider or local health department and the vaccinee.
Severe systemic hypersensitivity reactions (including anaphylaxis) to egg protein,
gelatin, neomycin, or streptomycin are contraindications for vaccines that contain these
products (e.g., influenza vaccines). Live virus vaccines are generally contraindicated for
adults who are immunocompromised and for women who are pregnant. These impor-
tant contraindications affect only a small number of adults. Adults who need vac-
cine are more likely to not be offered it because of misconceptions concerning
contraindications (see Box).
Standard 5: Recordkeeping
Each time an adult receives a dose of vaccine, the following information should be
recorded: vaccinee’s name, age, preexisting health conditions, type of vaccine, dose,
site and route of administration, name of the vaccine provider, date vaccine was ad-
ministered, manufacturer and lot number, and date that the next dose is due. If pos-
sible, this information should be recorded in the vaccinee’s medical file, sent to their
primary-care provider, and given to the vaccinee. Retrievable files also should be main-
tained by the vaccine provider in compliance with general medical practice and state
requirements.
Many adults do not have a primary-care provider and, even if they do, vaccine is
often not administered by their primary-care provider. Geographic and occupational
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mobility, changes in sources of health care, and economic factors often cause adults to
see several health-care providers throughout their lifetime. As a result, vaccination
records are often dispersed among a number of health-care providers. When vaccine is
administered by a health-care provider other than the vaccinee’s primary-care provider
(e.g., vaccine received in a nontraditional setting), a vaccine card with the information
noted in this standard should be provided to the primary-care provider or local health
department (if no such provider can be identified) and the vaccinee. When possible,
reminder notices should be sent to adults alerting them of when they are due for an-
other vaccination.
  BOX. Contraindications to Immunization*
True Contraindications False Contraindications
(Do Not Administer Vaccine)  (Vaccine May be Administered)
• Anaphylactic reaction to a vaccine. • Mild to moderate local reaction
following a dosage of an injectable
• Anaphylactic reaction to a vaccine antigen.
component.
• Low-grade or moderate fever
• Moderate or severe illness with or following a previous vaccine dosage.
without fever.
• Mild acute illness with or without
• Pregnancy. fever.
• Compromised immune system. • Current antimicrobial therapy.
• Convalescent phase of illness.
• Prematurity.
• Recent exposure to an infectious
disease.
• History of penicillin or other
nonspecific allergies or fact that
relatives have such allergies.
• Pregnancy of mother or household
contact.
• Unvaccinated household contact.
• Breast-feeding.
*This table is a modified version of the National Vaccine Advisory Committee’s Standards for
Pediatric Immunization Practices (CDC. Standards for pediatric immunization practices:
recommendations of the National Vaccine Advisory Committee. MMWR 1993;42[No. RR-5]).
Please consult with CDC’s National Immunization Program for updates.
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Standard 6: Vaccine Administration
Health-care providers who administer vaccine must have the legal authority to do
so and must be appropriately trained and licensed in all aspects of vaccine administra-
tion, including a) proper storage and handling of vaccines, b) information to be elicited
from clients before vaccination (Standard 3), c) information to be given to clients be-
fore vaccination (Vaccine Information Statements), d) techniques for vaccine adminis-
tration (20 ), and e) ability to handle adverse reactions.
Specific information regarding the recommended route of administration and ap-
propriate dose is included in the package insert of each vaccine. Most vaccines are
administered intramuscularly or subcutaneously. The dose indicated in the insert should
be the dose administered. Administering one half of the recommended dose to poten-
tially reduce the risk for adverse reaction has not been demonstrated to be an effective
method of reducing adverse reactions and could result in inadequate protection against
disease (26 ).
Standard 7: Adverse Events
Vaccine providers must be trained to recognize and treat adverse reactions, and the
equipment needed to do so must be available on site. Vaccines are safe and effective;
however, adverse events, ranging from minor, local reactions to severe systemic ill-
ness, occasionally occur following vaccination. Although severe, systemic reactions
are rare, they can be life-threatening. Vaccine providers should be trained to use medi-
cations (epinephrine, atropine, and sodium bicarbonate) and conduct procedures nec-
essary to maintain the airway and manage cardiovascular collapse (basic and advanced
cardiopulmonary resuscitation [CPR], operation of a defibrillator, and use of a self-
reinflating ventilating bag [Ambu bag] to provide positive pressure ventilation during
resuscitation). Vaccine providers must be in close proximity to a telephone so that emer-
gency medical personnel can be summoned immediately, if necessary.
Vaccinees should be monitored for adverse reactions after receiving vaccine. If a
severe adverse reaction occurs while the vaccinee is on site or any time after receiving
vaccine, the primary-care provider or local health department should be notified.
To improve knowledge about vaccines and vaccine-associated adverse reactions,
all serious adverse events should be reported to the Vaccine Adverse Event
Reporting System (VAERS) (21 ). VAERS reporting forms and assistance can be
obtained by telephone (1-800-822-7967) or through the CDC Internet site at
<http://www.cdc.gov/nip/vaers.htm>.
CONCLUSION
The ability of vaccines to save lives and prevent suffering extends beyond child-
hood. As with childhood vaccines, adult vaccines are a cost-effective means of prevent-
ing disease (27,28 ). To realize these benefits, vaccines must be made readily available
to the public. Although rates of vaccine coverage among adults are increasing, many
adults (especially among economically disadvantaged, inner city, and minority popula-
tions) are not receiving appropriate vaccinations (2 ). Enhancing educational efforts
and increasing the number and types of programs (e.g., standing orders [29] and non-
traditional settings) safely administering vaccine to adults might increase the number
of adults receiving vaccines and the associated benefits.
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Educating health-care providers and the public is the cornerstone of an effective
vaccination strategy. The Adult Immunization Action Plan (1 ) emphasizes the need for
physicians and other health-care providers to recognize both the severity of influenza
and pneumococcal disease and the safety and effectiveness of vaccines so they consis-
tently offer vaccines to their patients. Physicians’ recommendations influence patients’
decisions to receive vaccine, regardless of the patients’ initial attitude (6 ). However,
some adults who need vaccination receive medical care but are not offered vaccine,
whereas others might not have regular contact with traditional health-care settings.
For these reasons, increased efforts to educate the public as well as health-care
providers are needed. The 1994 NVAC report on adult immunization concluded that
“better public understanding of the seriousness of vaccine-preventable diseases and
the benefits of vaccination will be essential if there are to be improvements in adult
immunization” (30 ).
An essential step toward creating an effective immunization infrastructure integrat-
ing traditional and nontraditional immunization programs is to determine the role each
type of program has in the overall immunization strategy. Data from immunization
programs in traditional and nontraditional settings are needed to assess who receives
vaccine in which settings and why they choose that setting. Data characterizing per-
sons who do not receive vaccine and their reasons for not getting vaccinated also are
needed. These data will facilitate the development of a comprehensive immunization
strategy to increase immunization coverage in all segments of the adult population.
Integration of nontraditional immunization programs with the existing health-care
infrastructure provides the potential to increase vaccine coverage rates and decrease
vaccine-preventable diseases among adults. To do so most effectively, the specific con-
tributions of immunization programs in traditional and nontraditional settings need to
be established, and the quality standards in this report need to be implemented. The
efforts that effectively lowered vaccine-preventable disease rates among children now
need to be targeted toward developing new and effective immunization programs that
will make appropriate vaccines readily accessible to adults.
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Use of Standing Orders Programs to Increase
Adult Vaccination Rates
Recommendations of the Advisory Committee
on Immunization Practices
Summary
The Advisory Committee on Immunization Practices recognizes the need for
evidence-based policy to improve the delivery and receipt of immunization
services recommended for adults (i.e., persons aged 18 years). Two recent,
systematic reviews of the health services research literature recommended
standing orders programs as an effective organizational intervention to improve
vaccination coverage rates among adults. This report briefly reviews the
evidence on the effectiveness of standing orders programs, describes standards
for program implementation, and recommends initiating these programs to
improve immunization coverage in several traditional and nontraditional
settings.
INTRODUCTION
Standing orders programs authorize nurses and pharmacists to administer vaccina-
tions according to an institution- or physician-approved protocol without a physician’s
exam. These programs have documented improved vaccination rates among adults.
Standing orders programs can be used in inpatient and outpatient facilities, long-term–
care facilities, managed-care organizations, assisted living facilities, correctional facili-
ties, pharmacies, adult workplaces, and home health-care agencies to vaccinate pa-
tient, client, resident, and employee populations. The Advisory Committee on Immuni-
zation Practices (ACIP) recommends standing orders for influenza and pneumococcal
vaccinations (1,2 ). Recently, systematic literature reviews by the Task Force for Com-
munity Preventive Services (3 ) and the Southern California Evidence-Based Practice
Center–RAND endorsed these programs for adult populations (4 ).
This report briefly reviews the evidence regarding the effectiveness of standing or-
ders programs in improving adult vaccination coverage rates and recommends priori-
tizing these programs for influenza and pneumococcal vaccinations, to have the great-
est impact on the burden of vaccine-preventable diseases in the United States. Stand-
ing orders programs are also recommended for other vaccines, including hepatitis B
vaccine and diphtheria and tetanus toxoid vaccines, when feasible.
BACKGROUND
Epidemics of influenza occur during the winter months nearly every year and are
responsible for an average of approximately 20,000 deaths per year in the United States
(5,6 ). Influenza viruses cause disease in all age groups (7,8 ), but rates of serious mor-
bidity and mortality are highest among persons aged 65 years and persons of any age
who have medical conditions that place them at high risk for complications from influ-
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enza (2,9–11 ). Pneumococcal disease accounts for approximately 3,000 cases of men-
ingitis, 50,000 cases of bacteremia, and 500,000 cases of pneumonia each year (1 ) and
is responsible for more deaths than any other vaccine-preventable bacterial disease
(12 ). Despite antimicrobial therapy and intensive medical care, the overall case-fatality
rate for pneumococcal bacteremia is 15%–20% among adults (i.e., persons aged 18
years) (1 ). Among persons aged 65 years, case-fatality rates can be as high as
40% (13 ).
In recent years, a rapid emergence of antimicrobial resistance among pneumococci,
especially to penicillin, has occurred. Increasing pneumococcal vaccination rates could
help prevent invasive pneumococcal disease caused by vaccine-type, multidrug-
resistant pneumococci. Outbreaks of pneumococcal disease caused by a single drug-
resistant pneumococcal serotype have occurred in institutional settings, including nurs-
ing homes (14,15 ). In 1999, because of concerns about pneumococcal antimicrobial
resistance and underuse of pneumococcal vaccine, the American Medical Association
and several partner organizations issued a Quality Care Alert that supports ACIP’s rec-
ommendations for pneumococcal vaccination (16 ).
Health services research indicates that influenza and pneumococcal vaccines are
underused in institutional settings, even after they became covered benefits of Medi-
care Part B (1981 for pneumoccocal vaccine and 1993 for influenza vaccine) (17,18 ).
Despite the availability of suitable vaccines, persons hospitalized with conditions for
which influenza and pneumococcal vaccines are indicated are not usually assessed for
vaccination status or vaccinated. Among persons who reported at least one hospital-
ization during the preceding year to the 1997 National Health Interview Survey, 83% of
persons aged 18–64 years with medical conditions that put them at high risk and 55% of
all persons aged 65 years reported not receiving pneumococcal vaccinations (CDC,
unpublished data, 1999). Sixty-nine percent of persons aged 18–64 years with medical
conditions that put them at high risk and 32% of all persons aged 65 years reported
not receiving influenza vaccination (CDC, unpublished data, 1999). In 12 western states,
80% of Medicare beneficiaries hospitalized for pneumonia during September–Decem-
ber 1994 did not receive influenza vaccines; 65% did not receive pneumococcal vac-
cines (17 ). The 1995 National Nursing Home Survey estimated influenza and pneumo-
coccal vaccination rates among residents in long-term–care facilities to be approxi-
mately 63% and 22%, respectively (18 ). These rates are far below the Healthy People
2010  objective of 90% for both vaccines among all persons aged 65 years (objective
14-29) (19 ). Coverage estimates for 1997 were approximately 64% for influenza vac-
cines and 28% for pneumococcal vaccines (CDC, unpublished data, 1999). Many long-
term–care facilities have inadequate policies and procedures to prevent vaccine-pre-
ventable diseases among their vulnerable populations (20 ).
Several studies suggest that standing orders programs are more effective than other
institution-based strategies in improving vaccination services. In one New York hospi-
tal, instituting a standing orders program for pneumococcal vaccination among per-
sons aged 65 years and other patients at high risk increased the pneumococcal vacci-
nation rate from 0% to 78% (21 ). In another study, pharmacists increased pneumococ-
cal vaccination rates from 4.2% to 94% in one nursing facility and from 1.9% to 83% in
a second facility, whereas the rates at a control facility increased from 0.9% to 4.0%
(22 ). In a study of six small community hospitals in northern Minnesota, standing or-
ders programs achieved an influenza vaccination rate of 40.3% among patients, com-
pared with 17% using physician reminders and 9.6% using educational programs (23 ).
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A study conducted in an ambulatory care clinic compared the use of nurse standing
orders combined with other interventions, including patient and health-care provider
reminders, with the use of patient and provider reminders alone. Pneumococcal
vaccination rates per total patient population were 22%–25% for the nurse standing
orders programs, compared with 5% when patient and provider reminders were used
alone (24 ).
Based on the scientific evidence of effectiveness in improving vaccination rates in
institutions, the Task Force for Community Preventive Services and the Southern Cali-
fornia Evidence-Based Practice Center–RAND recommend standing orders programs
for the vaccination of adults in hospitals, clinics, and nursing homes (3,4 ). Standing
orders policies are acceptable to most primary-care physicians (25 ) and have resulted
in higher vaccination rates than other vaccination delivery methods (4,26 ).
IMPLEMENTATION GUIDELINES
Successful standing orders programs begin by documenting a plan for the program’s
infrastructure, key service-delivery components, and quality assurance. To ensure suc-
cess, a committee should be formed that includes the organization’s medical director,
nursing director, infection-control and quality-control personnel, and medical or nurs-
ing staff representatives. This committee should write protocols for the following pro-
cedures:
• Identifying persons eligible for vaccination based on their age, their vaccination
status (e.g., persons previously unvaccinated or due for vaccination according to
the recommended schedule), or the presence of a medical condition that puts
them at high risk.
• Providing adequate information to patients or their guardians regarding the risks
for and benefits of a vaccine and documenting the delivery of that information.
• Recording patient refusals or medical contraindications.
• Recording administration of a vaccine(s) and any postvaccination adverse
events, according to institution- or physician-approved protocol.
• Providing documentation of vaccine administration to patients and their
primary-care providers.
Standing orders protocols should also specify that vaccines be administered by
health-care professionals trained to a) screen patients for contraindications to vaccina-
tion, b) administer vaccines, and c) monitor patients for adverse events, in accordance
with state and local regulations. Vaccine information statements developed by and avail-
able from CDC can be useful for risk/benefit counseling before administering a vaccine.
All health-care personnel administering vaccines or providing care to vaccinated per-
sons should be trained to report adverse outcomes to the Vaccine Adverse Events Re-
porting System (VAERS). The appropriate VAERS forms and contact information should
be readily available in all facilities delivering vaccines.
The standards for adult immunization practice established by the National Coalition
for Adult Immunization recommend that standing orders programs include a standard
personal and institutional immunization record to verify the immunization status of
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patients and staff members and to reduce the risk for inappropriate revaccination (27 ).
A patient’s primary-care provider should be able to override institutional standing or-
ders when medically appropriate. Ongoing communication between the primary-care
provider, vaccinee, and institutional staff members is recommended to reduce the pos-
sibility of inappropriate vaccinations.
None of the studies of standing orders programs for influenza and pneumococcal
vaccination reported unnecessary or inappropriate vaccinations (3,4,21–23,26 ). If re-
peated pneumococcal vaccinations did occur, studies have indicated that the risk for
adverse events beyond self-limited local reactions was minimal for a second dose ad-
ministered 2–5 years after the primary dose (1,28 ). The risk for self-limited local injec-
tion site reactions does not represent a contraindication to revaccination with pneumo-
coccal vaccine in recommended groups.
The policies and protocols for standing orders programs should include a quality
assurance process to maintain appropriate standards of care. The feasibility and cost-
effectiveness of standing orders programs in several settings need ongoing evalua-
tion, with particular attention to safety and tracking of vaccinations (29 ). For example,
preprinted admissions orders could improve the effectiveness of program staff mem-
bers to assess the vaccination status of patients and to provide information about the
risks for and benefits of administering vaccinations routinely upon admission to facili-
ties.
Facility staff members should consider other potential benefits (e.g., sustainability
over time) when developing standing orders programs (30 ). These programs could be
adapted to other preventive services (e.g., mammography) to improve delivery of those
services, and they could be used to improve clinic efficiency by reducing pressures on
physicians’ time (3 ).
CONCLUSION
ACIP recommends that standing orders programs be used in long-term–care facili-
ties under the supervision of a medical director to ensure the administration of recom-
mended vaccinations for adults. ACIP also encourages the introduction of standing
orders programs for vaccination of adults in other settings (e.g., inpatient and outpa-
tient facilities, managed-care organizations, assisted living facilities, correctional facili-
ties, pharmacies, adult workplaces, and home health-care agencies). Implementation
of standing orders programs alone or combined with other effective interventions can
help improve vaccination coverage by institutional providers (3,4,31 ). Because of the
societal burden of influenza and pneumococcal disease, implementation of standing
orders programs to improve adult vaccination coverage for these diseases should be a
national public health priority.
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